Exploring Alternatives to the Predominant Pharma Patent Model in the Global South and Impact of AI

DOI

10.2991/978-2-38476-547-8_10How to use a DOI?

Keywords

Patent; pool; AI; global south; TRIPS

Abstract

The transformative spirit of the TRIPS Agreement was widely seen as an encouraging force driving a transnational change in the era of globalisation and the interconnectivity of trade. However, 30 years have passed since then, and a closer look at the evaluation of this agreement over the course of almost 30 years gives us significant questions to ponder over, albeit from a public policy perspective, and reconciling the same with the envisaged system of Intellectual Property rights that the agreement desired to regulate in the first place. The scope of the current research was aligned with TRIPS and the pharmaceutical sector, delineating the crucial junctures of monopoly of patents vis-à-vis public health, which is a broader concern or a social justice issue. While IP is a development vehicle pushing innovation and incentive as it churns out profits, it is needless to mention, after an extensive discussion on the interface of global south issues with the international instruments, that the balance needs to be established every time in IP operation and execution, especially when sensitive sectors like health come into the picture. This balance is not only a system of distribution that enables the disadvantaged to gain access they deserve and need, but also a regulatory system so that innovation can progress without hindering man’s all-round development. Recent developments would also involve an investigation into how AI-driven technological boost can help in the process and what can be taken up in policy matters discussions.

Copyright

© 2026 The Author(s)

Open Access

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

TY  - CONF
AU  - Akash Chatterjee
PY  - 2026
DA  - 2026/03/05
TI  - Exploring Alternatives to the Predominant Pharma Patent Model in the Global South and Impact of AI
BT  - Proceedings of the International Conference on Socio Legal Intricacies of Artificial Intelligence (ICSLIAI 2026)
PB  - Atlantis Press
SP  - 73
EP  - 83
SN  - 2352-5398
UR  - https://doi.org/10.2991/978-2-38476-547-8_10
DO  - 10.2991/978-2-38476-547-8_10
ID  - Chatterjee2026
ER  -